Community-based Mobile-assisted Brief Intervention for Smoking Cessation

April 8, 2026 updated by: LUK Tzu Tsun, National University of Singapore

Mobile-assisted Brief Intervention for Smoking Cessation in Community-based Setting: a Pilot Randomised Controlled Trial

The goal of this pilot trial is to evaluate the feasibility of a mobile-assisted brief intervention for smoking cessation in community-based individuals in Singapore. Specific aims include:

  1. To assess how many eligible individuals accept the invitation to participate in the trial
  2. To assess the retention of the participants through 6 months after treatment initiation
  3. To assess the acceptability of the intervention in terms of participants' engagement and ratings
  4. To examine the intervention effect on abstinence outcomes

Participants will be randomly assigned to either the intervention group or control group and followed for 6 months from randomisation.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Singapore, Singapore
        • Recruiting
        • National University of Singapore
        • Contact:
        • Contact:
        • Principal Investigator:
          • Tzu Tsun Luk, PhD, RN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged 21 to 80 years
  • Smoked at least one cigarette daily
  • Able to communicate and read in English or Chinese
  • Own a smartphone with WhatsApp installed

Exclusion Criteria:

  • Exposed to any smoking cessation treatment in the past 3 months
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobile-assisted brief intervention
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model and a 24-page self-help booklet.
Research personnel will assist the participant in signing up for the I Quit Programme to receive additional cessation support, unless they decline
Participants will receive personalised chat-based support delivered by a live counsellor for 3 months via WhatsApp. The message will incorporate behaviour change techniques for smoking cessation and mindfulness principles to strengthen participants' capacity to quit smoking.
Active Comparator: Brief advice
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model and a 24-page self-help booklet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Retention rate
Time Frame: 6 months
Number of participants completed the follow-up divided by the number of participants
6 months
Recruitment rate
Time Frame: 6 months
Number of participants divided by the number of eligible subjects
6 months
Biochemically validated smoking abstinence rate
Time Frame: 6 months
Defined as an exhaled carbon monoxide level of <5 parts per million or a negative salivary cotinine test (cut off 30ng/mL)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported 7-day point-prevalence smoking abstinence rate
Time Frame: 3 months
Being completely smoke-free in the past 7 days
3 months
Self-reported 7-day point-prevalence smoking abstinence rate
Time Frame: 6 months
Being completely smoke-free in the past 7 days
6 months
Self-reported smoking reduction rate
Time Frame: 3 months
Smoking reduction by at least half of the baseline daily number of cigarettes in individuals who continue to smoke
3 months
Self-reported smoking reduction rate
Time Frame: 6 months
Smoking reduction by at least half of the baseline daily number of cigarettes in individuals who continue to smoke
6 months
Self-reported quit attempt rate
Time Frame: 3 months
Serious quit attempt that lasted 24 hours or longer
3 months
Self-reported quit attempt rate
Time Frame: 6 months
Serious quit attempt that lasted 24 hours or longer
6 months
Smoking cessation service use rate
Time Frame: 3 months
Use of any smoking cessation service during the follow-up period
3 months
Smoking cessation service use rate
Time Frame: 6 months
Use of any smoking cessation service during the follow-up period
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tzu Tsun Luk, PhD, RN, National University of Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

March 31, 2027

Study Registration Dates

First Submitted

January 22, 2026

First Submitted That Met QC Criteria

January 22, 2026

First Posted (Actual)

January 29, 2026

Study Record Updates

Last Update Posted (Actual)

April 9, 2026

Last Update Submitted That Met QC Criteria

April 8, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • NUS-IRB-2025-690

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking &Amp; Tobacco Cessation

Clinical Trials on Brief cessation advice + self-help booklet

Subscribe